James Mcculloch
#120,876
Most Influential Person Now
James Mcculloch's AcademicInfluence.com Rankings
James Mccullochbiology Degrees
Biology
#7333
World Rank
#10236
Historical Rank
Neuroscience
#936
World Rank
#975
Historical Rank
Download Badge
Biology
Why Is James Mcculloch Influential?
(Suggest an Edit or Addition)James Mcculloch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion (1981) (1425)
- The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat (1988) (550)
- Cerebral Blood Flow and Metabolism (1993) (546)
- Reversible neural inactivation reveals hippocampal participation in several memory processes (1999) (496)
- Calcitonin gene-related peptide: functional role in cerebrovascular regulation. (1986) (468)
- Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P (1985) (401)
- Protective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the Cat (1988) (377)
- Focal Cerebral Ischaemia in the Rat: 2. Regional Cerebral Blood Flow Determined by [14C]Iodoantipyrine Autoradiography following Middle Cerebral Artery Occlusion (1981) (329)
- Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the cat (1983) (323)
- Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. (1987) (313)
- Calcitonin Gene-Related Peptide and Cerebral Blood Vessels: Distribution and Vasomotor Effects (1987) (289)
- Cerebral circulation and norepinephrine: relevance of the blood-brain barrier. (1976) (284)
- Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. (1990) (284)
- Endothelin-1-Induced Reductions in Cerebral Blood Flow: Dose Dependency, Time Course, and Neuropathological Consequences (1993) (250)
- Focal Cerebral Ischaemia in the Cat: Treatment with the Glutamate Antagonist MK-801 after Induction of Ischaemia (1988) (242)
- Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. (1981) (198)
- Focal cerebral ischemia in the rat: Topography of hemodynamic and histopathological changes (1984) (184)
- Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion (1985) (179)
- Nimodipine and the Haemodynamic and Histopathological Consequences of Middle Cerebral Artery Occlusion in the Rat (1986) (151)
- Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. (1984) (150)
- Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. (1990) (147)
- Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. (1991) (145)
- Recirculation model following MCA occlusion in rats. Cerebral blood flow, cerebrovascular permeability, and brain edema. (1985) (144)
- Influence of endogenous norepinephrine on cerebral blood flow and metabolism. (1976) (142)
- Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. (1992) (141)
- Acquired QT interval prolongation and HERG: implications for drug discovery and development. (2004) (136)
- Drug development for stroke: importance of protecting cerebral white matter. (1999) (135)
- Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide. (1980) (135)
- Nerve Fibers Containing Neuropeptide Y in the Cerebrovascular Bed: Immunocytochemistry, Radioimmunoassay, and Vasomotor Effects (1987) (132)
- Mapping Functional Alterations in the CNS With [14C]Deoxyglucose (1982) (132)
- Effect of Apomorphine on the Relationship between Local Cerebral Glucose Utilization and Local Cerebral Blood Flow (with an Appendix on its Statistical Analysis) (1982) (129)
- The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis (1989) (126)
- Potential Animal Models of Lacunar Stroke: A Systematic Review (2009) (121)
- A functional role for vasoactive intestinal polypeptide in anterior cingulate cortex (1983) (120)
- Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus (1991) (119)
- Focal Cerebral Ischemia in the Cat: Pretreatment with a Competitive NMDA Receptor Antagonist, D-CPP-ene (1990) (117)
- The Lipid Peroxidation By-product 4-Hydroxynonenal is Toxic to Axons and Oligodendrocytes (2000) (115)
- Rapid Disruption of Axon–Glial Integrity in Response to Mild Cerebral Hypoperfusion (2011) (114)
- Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia (1992) (114)
- The distribution of alterations in energy metabolism in the rat brain produced by apomorphine (1982) (113)
- Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use (1989) (113)
- Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat (1990) (112)
- Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice (2004) (111)
- Stroke Research Priorities for the Next Decade – A Representative View of the European Scientific Community (2006) (108)
- Intracranial haemorrhage induced at arterial pressure in the rat. Part 2: Short term changes in local cerebral blood flow measured by autoradiography. (1984) (108)
- Feline cerebral veins and arteries: comparison of autonomic innervation and vasomotor responses (1982) (105)
- Rapid Alteration of Tau in Oligodendrocytes After Focal Ischemic Injury in the Rat: Involvement of Free Radicals (1997) (104)
- MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice (2011) (101)
- Effect of the NMDA Antagonist MK-801 on Local Cerebral Blood Flow in Focal Cerebral Ischaemia in the Rat (1989) (97)
- Influence of dopaminergic systems on the lateral habenular nucleus of the rat (1980) (95)
- Distribution of effects of haloperidol on energy metabolism in the rat brain (1982) (93)
- Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist. (1991) (92)
- Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion (1997) (92)
- CORRELATION OF TRIPHENYLTETRAZOLIUM CHLORIDE PERFUSION STAINING WITH CONVENTIONAL NEUROHISTOLOGY IN THE DETECTION OF EARLY BRAIN ISCHAEMIA (1988) (91)
- Effect of the Calcium Antagonist Nimodipine on Local Cerebral Blood Flow and Metabolic Coupling (1985) (89)
- Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death (2007) (85)
- The Role of Mitochondria in Glioma Pathophysiology (2010) (83)
- Inhibition of Nitric Oxide Synthesis: Effects on Cerebral Blood Flow and Glucose Utilisation in the Rat (1993) (83)
- Selective white matter pathology induces a specific impairment in spatial working memory (2011) (82)
- Neuroprotective Effect of the AMPA Receptor Antagonist LY-293558 in Focal Cerebral Ischemia in the Cat (1994) (82)
- Effects of MK-801 upon Local Cerebral Glucose Utilisation in Conscious Rats and in Rats Anaesthetised with Halothane (1989) (80)
- Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. (1999) (79)
- The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation (1990) (79)
- Effect of the Calcium Antagonist Nimodipine on Local Cerebral Blood Flow: Relationship to Arterial Blood Pressure (1984) (79)
- A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology (2006) (77)
- Endothelin Receptor Antagonist Increases Cerebral Perfusion and Reduces Ischaemic Damage in Feline Focal Cerebral Ischaemia (1996) (76)
- NMDA Receptor Blockade Fails to Alter Axonal Injury in Focal Cerebral Ischemia (2000) (75)
- Tachykinins (Substance P, Neurokinin A, Neuropeptide K, and Neurokinin B) in the Cerebral Circulation: Vasomotor Responses in vitro and in situ (1991) (75)
- Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. (1990) (74)
- Intraventricular Infusion of Apolipoprotein E Ameliorates Acute Neuronal Damage after Global Cerebral Ischemia in Mice (2000) (73)
- The effects of the GABAergic agonist muscimol upon the relationship between local cerebral blood flow and glucose utilization (1983) (71)
- Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences. (1985) (71)
- Robustness of G Proteins in Alzheimer's Disease: An Immunoblot Study (1991) (70)
- Cerebrovascular responses to capsaicin in vitro and in situ (1990) (70)
- Local Cerebral Glucose Utilization in Hypothermic and Hyperthermic Rats (1982) (68)
- Differential effects of competitive and non-competitive N-methyl-d-aspartate antagonists on glucose use in the limbic system (1988) (67)
- Contractile Responses to Endothelin in Feline Cortical Vessels in situ (1990) (67)
- Quantitative Assessment of Ischemic Pathology in Axons, Oligodendrocytes, and Neurons: Attenuation of Damage after Transient Ischemia (2000) (66)
- Transient glucose hypermetabolism after acute subdural hematoma in the rat. (1992) (66)
- Evaluation of a competitive NMDA antagonist (D‐CPPene) in feline focal cerebral ischemia (1991) (65)
- Specific alterations in local cerebral glucose utilization following striatal lesions (1982) (65)
- Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels. (1978) (65)
- Catecholamines and the relationship between cerebral blood flow and glucose use. (1986) (64)
- Glioma Pathophysiology: Insights Emerging from Proteomics (2010) (64)
- On the Stability of Messenger RNA and Ribosomal RNA in the Brains of Control Human Subjects and Patients with Alzheimer's Disease (1992) (64)
- Cerebral circulation: effect of stimulation and blockade of dopamine receptors. (1977) (60)
- Grey Matter and White Matter Ischemic Damage is Reduced by the Competitive AMPA Receptor Antagonist, SPD 502 (2002) (59)
- Interactions among mitochondrial proteins altered in glioblastoma (2014) (59)
- Cerebrovascular Smooth Muscle Reactivity: A Critical Appraisal of in vitro and in situ Techniques (1984) (58)
- Cerebrovascular permeability following MCA occlusion in the rat. The effect of halothane-induced hypotension. (1982) (58)
- The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia (1992) (57)
- Pharmacological modification of glutamate neurotoxicity in vivo (1993) (57)
- Cerebral circulatory and metabolism changes following amphetamine administration (1977) (57)
- Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics (2007) (56)
- Targeting Expression of hsp70i to Discrete Neuronal Populations Using the Lmo-1 Promoter: Assessment of the Neuroprotective Effects of hsp70i In vivo and In vitro (2001) (56)
- Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion (2001) (55)
- Reduced levels of calcitonin gene-related peptide-like immunoreactivity in human brain vessels after subarachnoid haemorrhage (1991) (55)
- Axonal injury caused by focal cerebral ischemia in the rat. (1998) (55)
- Local cerebral circulatory and metabolic effects of indomethacin. (1982) (54)
- Anti‐ischaemic efficacy of a nitric oxide synthase inhibitor and a N‐methyl‐d‐aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia (1994) (53)
- Specific distribution of metabolic alterations in cerebral cortex following apomorphine administration (1979) (52)
- The central noradrenergic system in the rat: Metabolic mapping with α-adrenergic blocking agents (1982) (51)
- The effects of dexamethasone administration and withdrawal on water permeability across the blood‐brain barrier (1983) (50)
- Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation. (2000) (49)
- Modification of Vasoconstrictor Responses in Cerebral Blood Vessels by Lesioning of The Trigeminal Nerve: Possible Involvement of CGRP (1995) (49)
- Functional role for vasoactive intestinal polypeptide in the caudate nucleus: a 2-deoxy[14C]glucose investigation. (1983) (48)
- Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists (1985) (47)
- Intracerebral injection of AMPA causes axonal damage in vivo (2003) (47)
- Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice (2004) (46)
- Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge (2011) (44)
- Retina-dependent activation by apomorphine of metabolic activity in the superficial layer of the superior colliculus. (1980) (44)
- Distribution and vasomotor effects of peptide HI (PHI) in feline cerebral blood vessels in vitro and in situ (1985) (44)
- Adaptive changes in the neuronal proteome: mitochondrial energy production, endoplasmic reticulum stress, and ribosomal dysfunction in the cellular response to metabolic stress (2013) (43)
- MIGRAINE AND THE BLOOD-BRAIN BARRIER (1977) (43)
- Specific expression of the cell cycle regulation proteins, GADD34 and PCNA, in the peri‐infarct zone after focal cerebral ischaemia in the rat (2002) (43)
- Effects of intracisternal endothelin-1 injection on blood flow to the lower brain stem. (1991) (42)
- Selective alterations of high affinity [3H]forskolin binding sites in Alzheimer's disease: a quantitative autoradiographic study (1990) (42)
- Neuropeptide Y and the Cerebral Circulation (1990) (42)
- Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat (1994) (41)
- 123Iodo-MK-801: a spect agent for imaging the pattern and extent of glutamate (NMDA) receptor activation in Alzheimer's disease. (1997) (41)
- Topographical and quantitative assessment of white matter injury following a focal ischaemic lesion in the rat brain. (1998) (40)
- Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) (40)
- AMPA receptor antagonists and local cerebral glucose utilization in the rat (1994) (40)
- Focal ischemic damage is reduced by CPP-ene studies in two animal models. (1990) (40)
- Alterations in Local Cerebral Glucose Utilization during Hemorrhagic Hypotension in the Rat (1982) (39)
- The effect of diazepam upon local cerebral glucose use in the conscious rat (1986) (39)
- Effects of Pentobarbital on Contractile Responses of Feline Cerebral Arteries (1981) (38)
- First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia (1997) (38)
- Efficacy of d-CPPene, a competitive N-methyl-d-aspartate antagonist in focal cerebral ischemia in the rat (1992) (38)
- Endothelin-B Receptors in Cerebral Resistance Arterioles and their Functional Significance after Focal Cerebral Ischemia in Cats (1997) (37)
- Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury (2007) (37)
- A radical approach to stroke therapy (2001) (37)
- Glutamate receptor antagonists in experimental focal cerebral ischaemia. (1993) (37)
- Cerebral ischemia induces alterations in tau and ubiquitin proteins. (1994) (36)
- Selective alterations in glutamate receptor subtypes after unilateral orbital enucleation (1991) (36)
- Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties. (1992) (36)
- The Effects of Apomorphine upon Local Cerebral Glucose Utilization in Conscious Rats and in Rats Anesthetized with Chloral Hydrate (1983) (35)
- Differential alterations in adenosine A1 and κ1 opioid receptors in the striatum in Alzheimer's disease (1993) (35)
- Focal brain injury: histological evidence of delayed inflammatory response in a new rodent model of focal cortical injury. (1994) (35)
- Ischaemic brain damage associated with tissue hypermetabolism in acute subdural haematoma: reduction by a glutamate antagonist. (1990) (35)
- Endothelin-Mediated Vascular Tone following Focal Cerebral Ischaemia in the Cat (1996) (34)
- Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat (1993) (34)
- Therapeutic Potential of Endothelin Receptor Antagonists in Experimental Stroke (1995) (34)
- Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease (1993) (33)
- Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist. (1994) (33)
- Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat (1996) (32)
- Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellum (1990) (32)
- Autoradiographic analysis of 3H-MK-801 (dizocilpine) in vivo uptake and in vitro binding after focal cerebral ischemia in the rat. (1992) (32)
- The Distribution of Ischaemic Damage and Cerebral Blood Flow After Unilateral Carotid Occlusion and Hypotension in the Rat (1984) (31)
- Autoradiographic Imaging of [3H]Phorbol 12,13‐Dibutyrate Binding to Protein Kinase C in Alzheimer's Disease (1991) (31)
- Selective reduction of [125I]apamin binding sites in Alzheimer hippocampus: a quantitative autoradiographic study (1991) (31)
- Glutamate receptor antagonists in cerebral ischaemia. (1994) (31)
- The effects of chloral hydrate anesthesia on the metabolic response in the substantia nigra to apomorphine (1981) (31)
- Impaired cerebral autoregulation 24 h after induction of transient unilateral focal ischaemia in the rat (2000) (30)
- Failure of an Endothelin Antagonist to Modify Hypoperfusion after Transient Global Ischaemia in the Rat (1996) (30)
- Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists. (1978) (30)
- Cerebral glucose utilization following striatal lesions: the effects of the GABA agonist, muscimol, and the dopaminergic agonist, apomorphine (1987) (29)
- Molecular mechanisms of neurite growth with AMPA receptor potentiation (2007) (29)
- A potential error in modifications of the [14C]2-deoxyglucose technique (1983) (29)
- Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977 (1993) (29)
- Functional consequences of unilateral lesion of the locus coeruleus: A quantitative [14C]2-deoxyglucose investigation (1984) (28)
- Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls. (1993) (28)
- Perivascular nerve fibres and the cerebral circulation (1984) (28)
- A critical appraisal of semi-quantitative analysis of 2-deoxyglucose autoradiograms (1983) (28)
- Cerebral circulatory and metabolic effects of piribedil. (1980) (28)
- Antagonism by (D-Pro2, D-Trp7,9)-substance P of the cerebrovascular dilatation induced by substance P. (1982) (28)
- The AMPA Receptor Potentiator LY404187 Increases Cerebral Glucose Utilization and c-fos Expression in the Rat (2004) (27)
- The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat. (1996) (27)
- New Method for the Quantitative Assessment of Axonal Damage in Focal Cerebral Ischemia (2002) (27)
- Alterations in neurotransmitter receptors and glucose use after unilateral orbital enucleation (1991) (27)
- Proteomic analysis of gliomas (2007) (27)
- Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat (2004) (26)
- A new experimental model of contusion in the rat. Histopathological analysis and temporal patterns of cerebral blood flow disturbances. (1996) (25)
- Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography (2005) (25)
- Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease (1993) (25)
- Extrastriatal circuits activated by intrastriatal muscimol: A[14C]2-deoxyglucose investigation (1984) (25)
- Ischaemic brain damage--prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors. (1991) (24)
- Phenylethylamine and cerebral blood flow (1977) (24)
- Differential Profile of Nix Upregulation and Translocation during Hypoxia/Ischaemia in Vivo Versus in Vitro (2005) (24)
- The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: effect of pretreatment with enadoline (a kappa receptor agonist) (1996) (24)
- Network generation enhances interpretation of proteomic data from induced apoptosis (2010) (24)
- 5HT2 receptors in dementia of the Alzheimer type: A quantitative autoradiographic study of frontal cortex and hippocampus (1990) (23)
- Action of dopamine agonists on brain vessels in vitro and after in vivo microapplication. (1977) (22)
- Synthesis of (R,R)123I-QNB, a spect imaging agent for cerebral muscarinic acetylcholine receptors in-vivo (1992) (21)
- The effect of norepinephrine on the spinal cord circulation and its possible implications in the pathogenesis of acute spinal trauma. (1977) (21)
- The effects of FG 7142 upon local cerebral glucose utilization suggest overlap between limbic structures important in anxiety and convulsions (1988) (21)
- Reduction in local cerebral blood flow induced by endothelin-1 applied topically to the middle cerebral artery in the rat. (1991) (21)
- Effects of apomorphine upon local cerebral blood flow. (1979) (21)
- Factors influencing the response of the cerebral circulation to phenylethylamine (1979) (20)
- Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions (2005) (19)
- Abnormalities in Non-Cholinergic Neurotransmitter Systems in Alzheimer’s Disease (1994) (19)
- Comparison of the effects of potassium and pH on the calibre of cerebral veins and arteries (1982) (19)
- Alterations in local cerebral glucose utilization during chronic treatment with an ACTH 4-9 analog. (1982) (19)
- Characterisation of the Bax-nucleophosmin interaction: the importance of the Bax C-terminus (2008) (19)
- Influence of α-receptor blocking agents upon metabolic activity in nuclei involved in central control of blood pressure (1982) (19)
- Impact of Age on the Cerebrovascular Proteomes of Wild-Type and Tg-SwDI Mice (2014) (19)
- Neurobiology: Peptides and the microregulation of blood flow in the brain (1983) (19)
- Endothelin receptor mediated constriction and dilatation in feline cerebral resistance arterioles in vivo. (1996) (19)
- Efficacy of Nimodipine in Cerebral Ischemia or Hemorrhage (1990) (18)
- Autoradiographic assessment of the effects of N-methyl-d-aspartate (NMDA) receptor antagonists in vivo (1991) (18)
- Changes in local microvascular permeability and in the effect of intervention with 21-aminosteroid (Tirilazad) in a new experimental model of focal cortical injury in the rat. (1996) (18)
- Preservation of [125I]galanin binding sites despite loss of cholinergic neurons to the hippocampus in Alzheimer's disease (1991) (18)
- Changes in extracellular glutamate concentration after acute subdural haematoma in the rat--evidence for an "excitotoxic" mechanism? (1990) (17)
- NEUROPEPTIDE Y AND CEREBRAL BLOOD FLOW (1985) (17)
- Regional cerebral perfusion during hypertension depends on the hypertensive agent (1986) (17)
- Vasomotor effects of dimethyl sulfoxide on cat cerebral arteries in vitro and in vivo. (1986) (17)
- Endothelin-1-induced hypertension: a consequence of medullary ischemia? (1991) (16)
- Potential Animal Models of Lacunar Stroke (2009) (16)
- Galanin receptor binding sites in the temporal and occipital cortex are minimally affected in Alzheimer's disease (1995) (16)
- Alterations in the N-Methyl-D-Aspartate Receptor Complex following Focal Cerebral Ischemia (1989) (15)
- Peptidergic mechanisms in the cerebral circulation (1987) (15)
- AMPA receptor antagonism attenuates MK-801-induced hypermetabolism in the posterior cingulate cortex (1995) (15)
- Flash and Pattern Reversal Visual Evoked Responses in Normal and Demented Elderly (1992) (15)
- Cerebrovascular effects of NG-nitro-L-arginine methylester are conserved under halothane anaesthesia. (1993) (14)
- The utility of functional interaction and cluster analysis in CNS proteomics (2009) (14)
- The cerebral metabolic effects of manipulating glutamatergic systems within the basal forebrain in conscious rats (1998) (14)
- The effect of postmortem delay on the distribution of microtubule-associated proteins tau, MAP2, and MAP5 in the rat. (1997) (14)
- Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex (1991) (14)
- Increased expression of macrophage receptor with collagenous structure (MARCO) in mouse cortex following middle cerebral artery occlusion (2005) (13)
- Heterogeneous depression of glucose utilization in the caudate nucleus by GABA agonists (1981) (13)
- Hormonal influence on water permeability across the blood-brain barrier. (1983) (13)
- Autoradiographic evaluation of forskolin and D1 dopamine receptor binding in a rat model of focal cerebral ischaemia (1992) (13)
- Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex (1990) (13)
- Capsaicin and blood-brain barrier permeability (1987) (12)
- Indirect sympathomimetic agents and cerebral blood flow and metabolism. (1978) (12)
- The proteomic response in glioblastoma in young patients (2014) (12)
- Different patterns of axonal damage after intracerebral injection of malonate or AMPA (2006) (12)
- Effects of Cholecystokinin Octapeptide on Pial Arteriolar Diameter (1984) (12)
- Proteomic data in meningiomas: post-proteomic analysis can reveal novel pathophysiological pathways (2011) (12)
- Reduction in [3H]glutamate binding in the visual cortex after unilateral orbital enucleation (1989) (12)
- Total variance should drive data handling strategies in third generation proteomic studies (2013) (12)
- Alterations in Local Cerebral Glucose Utilisation in Specific Thalamic Nuclei following Apomorphine (1981) (11)
- Cerebral glucose utilization in transgenic mice overexpressing heat shock protein 70 is altered by dizocilpine (2002) (11)
- Group II Selective Metabotropic Glutamate Receptor Agonists and Local Cerebral Glucose use in the Rat (1999) (11)
- Role of Vasoactive Intestinal Peptide and Peptide Histidine Isoleucine in the Cerebral Circulation (1988) (11)
- Effects of post-mortem delay on high affinity forskolin binding sites and adenylate cyclase activity in rat and human striatum and cerebral cortex (1993) (11)
- Chronic exposure of bovine aortic endothelial cells to native and oxidized LDL modifies phosphatidylinositol metabolism. (1994) (10)
- Vasomotor effects of atrial natriuretic peptides on feline pial arterioles (1987) (10)
- Kappa-1 opioid receptors of the temporal cortex are preserved in Alzheimer's disease (1994) (9)
- Effect of stimulation of dopaminergic receptors upon local cerebral blood flow. (1977) (9)
- Dopaminergic systems and the cerebral circulation. (1977) (9)
- The diagnosis of depression in patients with dementia: Use of the cambridge mental disorders of the elderly examination (CAMDEX) (1992) (8)
- Neuroprotective drug development in stroke: blood pressure and its impact. (1996) (8)
- A correlative study of calcium channel antagonist binding and local neuropathological features in the hippocampus in Alzheimer's disease (1992) (8)
- Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization (1987) (8)
- Differential alterations of ion channel binding sites in temporal and occipital regions of the cerebral cortex in Alzheimer's disease (1993) (7)
- Autoradiographic assessment of choroid plexus blood flow and glucose utilization in the unanesthetized rat. (1982) (7)
- Local cerebral glucose utilization after chronic electroconvulsive shock: implications for the mode of action of electroconvulsive therapy (1991) (7)
- Effect of chloral hydrate anaesthesia on the cerebral metabolic response to apomorphine administration. (1981) (7)
- Specific alterations in cardiovascular function and in glucose utilisation within lower brainstem nuclei following intracisternal neuropeptide Y in the conscious rat (1990) (7)
- Local cerebral glucose utilization in the AS/AGU rat: a mutant with movement disorders (1998) (7)
- Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischaemia in the rat (2003) (6)
- Differential effects of locus coeruleus lesions upon metabolic activity in CNS nuclei involved in cardiovascular regulation (1983) (6)
- Apolipoprotein E influences neuronal death and repair (2003) (6)
- Focal increases in [3H]forskolin and [3H]phorbol 12,13-dibutyrate binding in the rat brain following lesions of the medial septum (1993) (6)
- Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction? (1994) (6)
- Indirect sympathomimetics and cerebral blood flow and metabolism. (1977) (6)
- Intracortical Glutamate Perfusionin VivoInduces Cellular Alterations in Specific Protein Kinase C Isoforms and Amyloid Precursor Protein (1997) (6)
- Alterations of functional glucose use and ligand binding to second messenger systems following unilateral orbital enucleation (1991) (5)
- The Journal: The Next Millennium (2000) (5)
- Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats (2005) (5)
- 5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus. (1990) (5)
- Second messenger systems: functional role in cerebrovascular smooth muscle regulation. (1990) (5)
- Focal cerebral ischaemia induces corticotropin releasing factor (CRF) vascular immunoreactivity in rat occluded hemisphere (2007) (5)
- High affinity hippocampal [3H]-glibenclamide binding sites are preserved in Alzheimer's disease (1993) (5)
- Brain Edema Following Focal Cerebral Ischemia in the Rat (1984) (5)
- α‐Amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid‐mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein (2006) (5)
- Postischemic Hypoperfusion in Transient Global Ischemia: A Role for Endothelins? (1995) (5)
- The Effects of NMDA Antagonists on Intracranial Pressure in a Model of Acute Subdural Haematoma in the Rat (1993) (4)
- Effects of unilateral intrahippocampal injection of MK-801 upon local cerebral glucose utilisation in conscious rats (1990) (4)
- Distribution of effects of the κ-opioid agonist CI-977 on cerebral glucose utilization in rat brain (1994) (4)
- Local cerebral blood flow following the intrastriatal administration of vasoactive intestinal peptide or peptide histidine isoleucine in the rat (1990) (4)
- Agonist desensitisation of α1 adrenoceptors and endothelin‐1 receptors coupled to phosphatidylinositol metabolism (1994) (4)
- Proteomic Analysis of Mitochondria in APOE Transgenic Mice and in Response to an Ischemic Challenge (2012) (3)
- Peptidergic Innervation of the Cerebral Vasculature and its Functional Signfiicance (1989) (2)
- Th central noradrenergic system in the rat: metabolic mapping with alpha-adrenergic blocking agents. (1982) (2)
- Neuropeptide y importance in the cerebral circulation (1987) (2)
- Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide [proceedings]. (1979) (2)
- Proteomic Studies in Low-Grade Gliomas: What Have They Informed About Pathophysiology? (2013) (2)
- Cerebrovascular Disease: Beyond neuroprotection: the protection of axons and oligodendrocytes in cerebral ischemia (2002) (2)
- Calcitonin gene-related peptide : Functional role in cerebrovascular regulation ( trigeminal ganglia / cerebral circulation / perivascular nerves ) (2)
- Differential alterations of second messenger systems and cerebral glucose use following excitotoxic lesion of rat cerebral cortex (1991) (2)
- Dopaminergic influence upon the cerebral circulation in the anaesthetized baboon [proceedings]. (1977) (2)
- Chronic cerebral hypoperfusion causes myelin damage and is associated with a selective impairment in working memory (2009) (2)
- Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia (1994) (2)
- Glutamate: A Role in Both Cerebral Ischaemia and Dementia of the Alzheimer Type (1991) (1)
- Cerebral Hemodynamics in Man and Monkey (1982) (1)
- Intracortical glutamate perfusion in vivo induces cellular alterations in specific protein kinase C isoforms and amyloid precursor protein. (1997) (1)
- Metabolic Mapping with Deoxyglucose Autoradiography as an Approach for Assessing Drug Action in the Central Nervous System (2017) (1)
- Stroke: Mechanisms of Excitotoxicity and Approaches for Therapy (2007) (1)
- The effect of the acetylcholinesterase inhibitor velnacrine on memory and regional cerebral blood flow in Alzheimer's disease (1992) (1)
- Differences in Reactivity of Pial Arteries and Veins to Local Chemical Factors and Putative Neurotransmitters (1983) (1)
- Calcium Antagonists and Experimental Focal Cerebral Ischemia (1989) (1)
- Modest cholinergic deafferentation fails to alter hippocampal G-proteins (1999) (1)
- 72. Evaluation of 99Tcm-exametazime stabilized with cobalt chloride as a blood flow tracer in focal cerebral ischaemia (1994) (1)
- The Involvement of Endothelins in Cerebral Vasospasm and Stroke (2001) (1)
- Effects of Respiratory Depression on Cytoprotective Effect of the Competitive NMDA Antagonist, D-CPPene (1993) (1)
- Phenylethylamine, migraine and the cerebral circulation. (1977) (0)
- Head Injuries: A Target for Neuroprotection (1994) (0)
- Eric T MacKenzie, PhD (25 May 1950–2 March 2017) (2017) (0)
- The Acute Eeeects Of Capsaicin On The Cerebral Vasculature (1987) (0)
- Applications of Autoradiography to Drug Discovery (1993) (0)
- Brief communication Selective white matter pathology induces a specific impairment in spatial working memory (2011) (0)
- Temporal influence of CAA on cerebrovascular and white matter integrity in parallel with cognition in Tg-SwDI mice (2011) (0)
- Neuregulin Signaling in Brain Injury and in Animal Models of Ischemia (1999) (0)
- Mapping Cortical and Hippocampal Activation with an AMPA Receptor Potentiator in the Rat Brain Using c-fos Immunocytochemistry and [14C]2-deoxyglucose Autoradiography (2006) (0)
- By-Laws of the International Society for Cerebral Blood Flow and Metabolism, Inc. (1986) (0)
- Alzheimer ' s disease . flow and cognitive performance in Measurements of regional cerebral blood (0)
- Cerebrovascular Permeability and Ischemic Brain Damage Following MCA Occlusion in the Rat (1985) (0)
- S-4-3 Glutamate antagonists in animal models of cerebral ischaemia (1995) (0)
- Glutamate Antagonism as a Pharmacological Approach to Prevent Calcium Influx in Focal Cerebral Ischemia (1989) (0)
- The link between vascular disturbances and Alzheimer's disease (2010) (0)
- Effect of APOE genotype on hippocampal mitochondria in response to a mild ischemic challenge (2011) (0)
- The Effects of a Dihydropyridine Calcium Antagonist on Cerebral Blood Flow with and without Middle Cerebral Artery Occlusion (1989) (0)
- Pre- and Postsynaptic Cortical Glutamatergic Binding Sites in Alzheimer’s Disease (1990) (0)
- carotid occlusion and hypotension in the rat The distribution of ischaemic damage and cerebral blood flow after unilateral (2011) (0)
- Cerebellar Excitatory Amino Acid Binding Sites are Differentially Altered in Alzheimer’s Disease (1990) (0)
- Mapping the functional effects of the AMPA receptor potentiators LY450108 and LY451395 with 14C 2-deoxyglucose autoradiography (2005) (0)
- 25 – Neuropeptide Transmitters and Their Receptors (1997) (0)
- The kappa-1 opioid agonist enadoline: ischemic brain damage and cerebral blood flow after permanent middle-cerebral artery occlusion (1994) (0)
- Reports of Societies (1977) (0)
- DOPAMINERGIC ACTION ON BRAIN VESSELS (1979) (0)
- A18 NICOTINE REVERSES THE WORKING MEMORY DEFICIT OBSERVED IN MICE OVEREXPRESSING HUMAN CASPASE-3 (2005) (0)
- The Use of Microdialysis for Monitoring the Effect of the Neuroprotective Drug CI-977 on Extracellular Excitatory Amino Acids (1995) (0)
- Central effects of endothelin-1 on cerebral blood flow in the rat (1990) (0)
- The effect of noradrenaline on spinal cord blood flow. (1977) (0)
- Reversible neural inactivation reveals hippocampal particin several memory processesipation (1999) (0)
- Abstract 491: Nox4 Inhibition, by GKT 137831, Decreases Obesity-Associated Vascular Dysfunction and Pro-Fibrotic Effects (2013) (0)
- Influence of alpha-receptor blocking agents upon metabolic activity in nuclei involved in central control of blood pressure. (1982) (0)
- The Journal in 2001: Looking Forward and Looking Back (2001) (0)
This paper list is powered by the following services:
